COMMUNIQUÉS West-GlobeNewswire

ImmuCell Bolsters its Innovation Strategy with Appointments of Dr. Gilles Guillemette and Dr. Anthony DiMarco to the Board, and Moves to a Smaller Board of Independent Directors
13/04/2026
PORTLAND, Maine, April 13, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health biologics company that develops and markets products to improve calf health and [...]
Biomerica Reports Third Quarter Fiscal 2026 Financial Results
14/04/2026
IRVINE, Calif., April 13, 2026 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (“Biomerica” or the “Company”) a global provider of advanced medical diagnostic and therapeutic products today reported financial [...]
Spyre Therapeutics Announces Proposed Public Offering of its Common Stock
13/04/2026
WALTHAM, Mass., April 13, 2026 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (“Spyre” or the “Company”) (Nasdaq: SYRE), a clinical-stage biotechnology company advancing best-in-class antibody engineering, dose [...]
Allogene Therapeutics Announces Proposed Public Offering of $175 Million of Common Stock
13/04/2026
SOUTH SAN FRANCISCO, Calif., April 13, 2026 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO) today announced that it intends to offer and sell, in an underwritten public offering and subject to market and [...]
Revolution Medicines, Inc. Announces Proposed Offerings of Common Stock and Convertible Senior Notes
13/04/2026
REDWOOD CITY, Calif., April 13, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced its intention [...]
XORTX Announces Closing of Acquisition of Vectus Kidney Anti-fibrotic Asset
13/04/2026
• VB4-P5 – novel new chemical entity with potential to address significant unmet need in rare and large-market chronic kidney disease • CALGARY, Alberta, April 13, 2026 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" [...]
Celldex to Present at Upcoming Investor Conference
13/04/2026
HAMPTON, N.J., April 13, 2026 (GLOBE NEWSWIRE) -- Celldex (NASDAQ:CLDX) announced today that management will participate in a fireside chat at H.C. Wainwright’s 4th Annual Inflammatory Skin Disease Virtual Conference on [...]
Les données intermédiaires de l'essai pivot testant cema-cel mettent en évidence la solidité de la plateforme CAR-T allogénique de Cellectis
13/04/2026
NEW YORK, 13 avr. 2026 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth : ALCLS ; Nasdaq : CLLS), société de biotechnologie de stade clinique, qui utilise sa plateforme pionnière d'édition de génome pour développer des [...]
Celebrating National Medical Laboratory Week
13/04/2026
Proud to recognize dedicated and caring medical laboratory professionals who empower healthier Canadians Toronto, Ontario, April 13, 2026 (GLOBE NEWSWIRE) -- LifeLabs, Canada's leading provider of medical diagnostic [...]
IBA – ACQUISITION OF OWN SHARES
13/04/2026
Louvain-la-Neuve, Belgium, April 13 th , 2026 – 6 PM CET – In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code on Companies and Associations, Ion Beam Applications SA (“IBA”) [...]
EssilorLuxottica: Disclosure of transactions in own shares
13/04/2026
Disclosure of transactions in own shares Paris, France (April 13, 2026 - 6:00 pm) – In accordance with the authorization granted by the Annual Shareholders’ Meeting on April 30, 2025, EssilorLuxottica declares that on [...]
Sienna for Seniors Foundation $1 Million Gift Advances Healthy Aging Research at Ontario Tech University
13/04/2026
Contribution will support work exploring older adult well-being, happiness, engagement and connection Pictured (left to right): John Henry, Regional Chair, Durham Region; Nitin Jain, President and CEO, Sienna Senior [...]
Radical™ Catheter Technologies Announces U.S. FDA 510(k) Clearance for its 6F Neurovascular Catheter -- Broadening Access Across a Wide Range of Applications
13/04/2026
Radical Catheter Technologies Continues to Expand its Best-in-Class Patented Platform and Scale its Specialized Neurovascular Commercialization Team LOS GATOS, Calif., April 13, 2026 (GLOBE NEWSWIRE) -- Radical™ [...]
Centre for Neuro Skills Named to Newsweek’s America’s Greatest Midsize Workplaces in Health Care 2026
13/04/2026
Brain injury rehabilitation leader earns second consecutive national recognition; honored among top midsize healthcare employers as demand grows for purpose-driven, AI-resilient healthcare careers BAKERSFIELD, Calif., [...]
EssilorLuxottica: Déclaration de transactions sur actions propres
13/04/2026
Déclaration de transactions sur actions propres Paris, France (13 avril 2026, 18h00) – Conformément à l’autorisation octroyée par l’Assemblée Générale du 30 avril 2025, EssilorLuxottica déclare que le 7 avril 2026, les [...]
IBA – ACQUISITION D’ACTIONS PROPRES
13/04/2026
Louvain-la-Neuve, Belgique, 13 avril 2026 – 18h00 – Conformément à l'article 8:4 de l'arrêté royal du 29 avril 2019 portant exécution du Code belge des sociétés et associations, Ion Beam Applications SA ("IBA") [...]
Vital Hemp Gummies | Launch" Hemp Gummies Australia, NZ Or Canada Relieves Anxiety Effective Reduces Pain Relax Stress With Vital Hemp 2026
13/04/2026
Vital Hemp Gummies Advanced Hemp Formula 2026 for Australia, NZ & Canada Supports Stress Relief, Anxiety Reduction, Pain Management & Better Sleep Naturally New York City, April 13, 2026 (GLOBE NEWSWIRE) -- In [...]
Seer Confirms Receipt of Unsolicited Proposal and Director Candidate Nominations from Radoff-JEC Group
13/04/2026
No Stockholder Action Required at This Time REDWOOD CITY, Calif., April 13, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER) (“Seer” or the “Company”), the pioneer and trusted partner for deep, unbiased proteomic [...]
Genmab Presents the Safety and Tolerability of Rinatabart Sesutecan (Rina-S®) in Combination with Bevacizumab in Advanced Ovarian Cancer
13/04/2026
Media Release COPENHAGEN, Denmark; April 13, 2026 Phase 1/2 RAINFOL™-01 data showed the combination of rinatabart sesutecan (Rina-S ® ) and bevacizumab was tolerable, with no new safety signals in patients with advanced [...]

Pages